Compile Data Set for Download or QSAR
maximum 50k data
Found 15 Enz. Inhib. hit(s) with all data for entry = 6053
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106687(US8586571, 50)
Affinity DataIC50:  5nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106685(US8586571, 17)
Affinity DataIC50:  10nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106694(US8586571, 207)
Affinity DataIC50:  12nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106691(US8586571, 164)
Affinity DataIC50:  15nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106681(US8586571, 6)
Affinity DataIC50:  20nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106688(US8586571, 80)
Affinity DataIC50:  20nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106690(US8586571, 143)
Affinity DataIC50:  23nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106684(US8586571, 14)
Affinity DataIC50:  24nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106695(US8586571, 215)
Affinity DataIC50:  34nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106682(US8586571, 36)
Affinity DataIC50:  36nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106693(US8586571, 197)
Affinity DataIC50:  40nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106692(US8586571, 189)
Affinity DataIC50:  71nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106683(US8586571, 12)
Affinity DataIC50:  210nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106686(US8586571, 20)
Affinity DataIC50:  290nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRetinol-binding protein 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106689(US8586571, 121)
Affinity DataIC50:  790nMAssay Description:The action of the compound of the present invention to inhibit binding of RBP4 and retinol and TTR was evaluated using the Retinol-RBP4-TTR ELISA (hu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent